Apparent involvement of the A(2A) subtype adenosine receptor in the anti-inflammatory interactions of CGS 21680, cyclopentyladenosine, and IB- MECA with human neutrophils

Biochemical Pharmacology

Volumn 60, Issue 7, 2000, Pages 993-999

  Visser, Susanna S ^a   Theron, Annette J ^b   Ramafi, Grace ^b   Ker, James A ^a   Anderson, Ronald ^c  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

^c NONE

Author keywords

Adenosine; Calcium; CGS 21680; Cyclic AMP; Elastase; Neutrophils; Superoxide; ZM 241385

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR; ADENOSINE DERIVATIVE; CALCIUM ION; CYCLIC AMP; ELASTASE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; SUPEROXIDE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CALCIUM TRANSPORT; CHEMOLUMINESCENCE; COLORIMETRY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; SPECTROFLUOROMETRY;

ADENOSINE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL DEGRANULATION; CYCLIC AMP; FURA-2; HUMANS; NEUTROPHILS; PANCREATIC ELASTASE; PHENETHYLAMINES; REACTIVE OXYGEN SPECIES; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1;

EID: 0034308207     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00414-7     Document Type: Article

References (24)

1. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol. 76:1994;5-13.
2. Stiles G.L. Adenosine receptors. J Biol Chem. 267:1992;6451-6454.
3. Hannon J.P., Bray-French K.M., Phillips R.M., Fozard J.R. Further pharmacological characterization of the adenosine receptor subtype mediating inhibition of the oxidative burst in human isolated neutrophils. Drug Dev Res. 43:1998;214-224.
4. 3 receptor expression and function in eosinophils. Am J Respir Cell Mol Biol. 16:1997;531-537.
5. 3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release. Br J Pharmacol. 127:1999;188-194.
6. 2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leucocytes. Naunyn Schmiedebergs Arch Pharmacol. 354:1996;262-267.
7. 2A adenosine receptors on human neutrophils. Br J Pharmacol. 123:1998;1723-1731.
8. Rose F.R., Hirschhorn R., Weissmann G., Cronstein B.N. Adenosine promotes neutrophil chemotaxis. J Exp Med. 167:1988;1186-1194.
9. 3 receptors . J Immunol. 158:1997;5400-5408.
10. Fredholm B.B. Purines and neutrophil leucocytes. Gen Pharmacol. 28:1997;345-350.
11. 1 receptors. J Immunol. 148:1992;2201-2206.
12. 2 receptor on human neutrophils . J Immunol. 135:1985;1366-1371.
13. 2 receptor. Naunyn Schmiedebergs Arch Pharmacol. 346:1992;234-237.
14. Torphy T.J. Phosphodiesterase enzymes Molecular targets for novel antiasthma agents . Am J Respir Crit Care Med. 157:1998;351-370.
15. 2A selective adenosine receptor antagonist. Br J Pharmacol. 115:1995;1096-1102.
16. Minkenberg I., Ferber E. Lucigenin-dependent chemiluminescence as a new assay for NADPH-oxidase activity in particulate fractions of human polymorphonuclear leukocytes. J Immunol Methods. 71:1984;61-67.
17. Beatty K., Robertie P., Senior R.M., Travis J. Determination of oxidized alpha-1-proteinase inhibitor in serum. J Lab Clin Med. 100:1982;186-192.
18. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 260:1985;3440-3450.
19. Sullivan G.W., Linden J. Role of A(2A) adenosine receptors in inflammation. Drug Dev Res. 45:1998;103-112.
20. 2 receptors in rat brain. J Pharmacol Exp Ther. 251:1989;888-893.
21. 3H]CGS 21680 to human and rat brain Evidence for multiple affinity sites . J Neurochem. 55:1990;1763-1771.
22. Iannone M.A., Wolberg G., Zimmerman T.P. Chemotactic peptide induces cAMP elevation in human neutrophils by amplification of the adenylate cyclase response to endogenously produced adenosine. J Biol Chem. 264:1989;20177-20180.
23. Anderson R. Goolam Mahomed A, Theron AJ, Ramafi G and Feldman C, Effect of rolipram and dibutyryl cyclic AMP on resequestration of cysolic calcium in FMLP-activated human neutrophils. Br J Pharmacol. 124:1998;547-555.
24. Villagrasa V., Navarette C., Sanz C., Berto L., Perpina M., Cortijo J., Morcillo E.J. Inhibition of phosphodiesterase IV and intracellular calcium levels in human polymorphonuclear leukocytes. Methods Find Exp Clin Pharmacol. 18:1996;239-245.